Your browser doesn't support javascript.
loading
Efficacy of ruxolitinib in a patient with myelodysplastic/myeloproliferative neoplasm unclassifiable and co-mutated JAK2, SF3B1 and TP53.
Wang, Qian; Dai, Hai-Ping; Liu, Dan-Dan; Xie, Jun-Dan; Yao, Hong; Ding, Zi-Xuan; Tao, Ting-Ting; Chen, Su-Ning; Zhang, Ri.
Afiliación
  • Wang Q; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, NHC Key Laboratory of Thrombosis and Hemostasis, The First Affiliated Hospital of Soochow University, Suzhou, China.
  • Dai HP; Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China.
  • Liu DD; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, NHC Key Laboratory of Thrombosis and Hemostasis, The First Affiliated Hospital of Soochow University, Suzhou, China.
  • Xie JD; Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China.
  • Yao H; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, NHC Key Laboratory of Thrombosis and Hemostasis, The First Affiliated Hospital of Soochow University, Suzhou, China.
  • Ding ZX; Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China.
  • Tao TT; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, NHC Key Laboratory of Thrombosis and Hemostasis, The First Affiliated Hospital of Soochow University, Suzhou, China.
  • Chen SN; Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China.
  • Zhang R; National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, NHC Key Laboratory of Thrombosis and Hemostasis, The First Affiliated Hospital of Soochow University, Suzhou, China.
Leuk Res Rep ; 14: 100229, 2020.
Article en En | MEDLINE | ID: mdl-33194542

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Leuk Res Rep Año: 2020 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Leuk Res Rep Año: 2020 Tipo del documento: Article País de afiliación: China